Previous CNN based approaches to neuropathology immunohistochemistry (IHC) have proven successful at classifying tauopathies based on p-tau lesions [32], detecting and categorizing Aβ lesions [28, 34], and calculating alpha-synuclein burden from submandibular gland biopsy [33]. This evidence concerns the gene MAPT and tauopathy.